| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RAPT Therapeutics, Inc. | PRESIDENT AND CEO, Director | Common Stock | 0 | $0 | $57.72 | 03 Mar 2026 | Direct |
| RAPT Therapeutics, Inc. | PRESIDENT AND CEO, Director | Employee Stock Option (right to buy) | 265,625 | 03 Mar 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RAPT | RAPT Therapeutics, Inc. | 03 Mar 2026 | 11 | $0 | 4 | PRESIDENT AND CEO, Director | 05 Mar 2026, 08:55 |
| RAPT | RAPT Therapeutics, Inc. | 20 Jun 2025 | 1 | $0 | 4 | PRESIDENT AND CEO, Director | 24 Jun 2025, 16:19 |
| RAPT | RAPT Therapeutics, Inc. | 30 Jan 2025 | 1 | $0 | 4 | PRESIDENT AND CEO, Director | 03 Feb 2025, 18:22 |
| RAPT | RAPT Therapeutics, Inc. | 13 Nov 2024 | 12 | $0 | 4 | PRESIDENT AND CEO, Director | 15 Nov 2024, 20:00 |
| RAPT | RAPT Therapeutics, Inc. | 31 Jan 2024 | 1 | $0 | 4 | PRESIDENT AND CEO, Director | 01 Feb 2024, 20:40 |
| RAPT | RAPT Therapeutics, Inc. | 31 Jan 2023 | 1 | $0 | 4 | President and CEO, Director | 02 Feb 2023, 17:21 |
| RAPT | RAPT Therapeutics, Inc. | 28 Jan 2022 | 1 | $0 | 4 | President and CEO, Director | 14 Feb 2022, 18:12 |